Published: Mon, April 16, 2018
Business | By Tara Barton

Is the $168.35 Price Target For Accenture plc (NYSE:ACN) Achievable?

Moreover, Cranbrook Wealth Mngmt Limited Liability Company has 0.01% invested in Accenture plc (NYSE:ACN) for 121 shs. The stock decreased 2.77% or $0.85 during the last trading session, reaching $29.8. For technical analysis of stock and trends here we employ the use of tools such as trading volume, Simple Moving averages, RSI (14), and ATR (14) to determine the future behavior of a stock. It has underperformed by 11.55% the S&P500. First Personal Financial Service holds 1.8% in Accenture plc (NYSE:ACN) or 60,500 shs. Martin Currie Ltd sold 7,811 shares as the company's stock declined 3.27% with the market. The hedge fund run by Mitch Cantor held 450,000 shares of the consumer services company at the end of 2017Q4, valued at $19.75M, down from 544,500 at the end of the previous reported quarter. Suncoast Equity Management who had been investing in Accenture Ltd for a number of months, seems to be less bullish one the $96.55 billion market cap company. The median estimate represents a 150.13% increase from the last price. 1,607,799 shares of the stock were exchanged, compared to its average volume of 2,898,337. Accenture plc (NYSE:ACN) has risen 24.68% since April 15, 2017 and is uptrending. It has outperformed by 13.13% the S&P500. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. Therefore 88% are positive. Abbott Laboratories had 105 analyst reports since July 24, 2015 according to SRatingsIntel. The stock's average target of $87 is -0.31% below today's ($87.27) share price. On Tuesday, March 20 the company was maintained by Wedbush. Bank of America has "Buy" rating and $23 target. On Thursday, November 2 Jefferies maintained Accenture plc (NYSE:ACN) rating. Also, the Hold rating count is 0, as of 13 April 2018. Zacks Investment Research downgraded Accenture PLC from a "buy" rating to a "hold" rating in a research report on Tuesday, December 13th. The firm has "Outperform" rating given on Wednesday, February 7 by BMO Capital Markets.

Investors sentiment decreased to 0.93 in 2017 Q4. Its down 0.19, from 0.69 in 2017Q3. The SI to Accenture Plc Class A Ordinary Shares (ireland)'s float is 1.43%. The ratio is more positive, as 82 funds started new or increased positions, while 67 decreased and sold their positions in Agios Pharmaceuticals Inc. Following the transaction, the insider now directly owns 21,034 shares of the company's stock, valued at approximately $2,474,650.10. Palouse Cap, Washington-based fund reported 160,423 shares. Baird reiterated a "hold" rating and set a $155.00 price objective on shares of Accenture in a research report on Thursday, December 7th. Wendell David Associates Incorporated holds 41,169 shares or 1.08% of its portfolio. 5,380 were reported by Sunbelt Inc. The 14-day RSI is now sitting at 45.46, the 7-day is at 48.28, and the 3-day is spotted at 54.53 for Accenture plc (NYSE:ACN). The Massachusetts-based Fernwood Investment Management Llc has invested 0.84% in the stock. Bbva Compass Bancorporation holds 0.15% or 138,178 shares in its portfolio. Prtn Grp Holdg Ag reported 1.04 million shares. Ckw invested in 5,600 shares. The New York-based Ny State Teachers Retirement System has invested 0.02% in American Campus Communities, Inc. Maryland Capital stated it has 3,100 shares or 0.07% of all its holdings. Reynders Mcveigh Mngmt Limited Co reported 4,720 shs.

Analysts await General Electric Company (NYSE:GE) to report earnings on April, 20. The company's revenue for the quarter was up 15.2% compared to the same quarter a year ago. GE's profit will be $1.04B for 28.15 P/E if the $0.12 EPS becomes a reality. It's up from 55,497 at the end of the previous reported quarter.

PM Abbasi to lead Pak delegation at CHOGM summit
Ahead of the formal Heads of Government Meeting on Thursday and Friday, there will be three days of forums on Business, Women, People and Youth.

Since January 1, 0001, it had 1 buying transaction, and 19 sales for $16.87 million activity.

Agios Pharmaceuticals Inc (AGIO) investors sentiment increased to 1.22 in 2017 Q4. It's up 0.01, from 1.21 in 2017Q3. It is negative, as 46 investors sold ACN shares while 393 reduced holdings. 108 funds amassed positions and 300 increased positions. The company reported $1.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.09. Ubs Asset Mgmt Americas has invested 0.36% in Accenture plc (NYSE:ACN).

According to Zacks brokerage recommendations, Accenture plc (NYSE:ACN)'s Buy count is 1 and Strong Buy is 12 while the number of analysts recommending Sell and Strong Sell are 0 and 8, respectively. Bryn Mawr Tru Com stated it has 4,866 shares. 3,522 were accumulated by Private Wealth Advisors Inc. Virtus Investment Advisers reported 331,774 shares or 0.1% of all its holdings. (NASDAQ:CAR) to report earnings on May, 2. (NYSE:ACC). Fmr Lc accumulated 2.02 million shares. Kbc Group Nv has 0.16% invested in Accenture plc (NYSE:ACN) for 121,232 shares. Nasdaq Journal (NJ) makes sure to keep the information up to date and correct, but we didn't suggest or recommend buying or selling of any financial instrument, unless that information is subsequently confirmed on your own. Landscape Capital Management Ltd Liability Corp reported 4,694 shares stake. Highbridge Cap Management Limited Com accumulated 7,489 shares or 0.02% of the stock. The firm's revenue was up 15.2% compared to the same quarter last year. sell-side analysts anticipate that Accenture will post 6.69 earnings per share for the current year. Therefore 58% are positive. Accenture had 31 analyst reports since October 23, 2017 according to SRatingsIntel. KeyCorp upped their target price on shares of Accenture from $157.00 to $172.00 and gave the stock an overweight rating in a research note on Saturday, December 30th. The firm has "Hold" rating by Morgan Stanley given on Friday, June 16. RBC Capital Markets maintained Accenture plc (NYSE:ACN) on Thursday, December 21 with "Buy" rating. Nomura maintained the stock with "Buy" rating in Friday, April 28 report. The company was downgraded on Monday, April 3 by Goldman Sachs. The rating was maintained by Cowen & Co with "Buy" on Monday, October 23. The rating was initiated by Wedbush on Friday, September 9 with "Outperform".

Like this: